237 related articles for article (PubMed ID: 5062254)
1. Central nervous system effects of fenfluramine hydrochloride.
Ziance RJ; Sipes IG; Kinnard WJ; Buckley JP
J Pharmacol Exp Ther; 1972 Jan; 180(1):110-7. PubMed ID: 5062254
[No Abstract] [Full Text] [Related]
2. Evidence that in rats 1-benzyl- -methoxy-3-trifluoromethylphenethylamine (SK& F 1-39728) dissociates anorexia from central stimulation and actions on brain monoamine stores.
Groppetti A; Misher A; Naimzada M; Revuelta A; Costa E
J Pharmacol Exp Ther; 1972 Sep; 182(3):464-73. PubMed ID: 5055405
[No Abstract] [Full Text] [Related]
3. [Central effects of betamezide].
Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
[No Abstract] [Full Text] [Related]
4. Antagonism of psychostimulant 2-phenyl-5,5-dimethyl-tetrahydro-1,4-oxazine hydrochloride (G 130) to central nervous system depressing drugs. Monoamine oxidase inhibitory activity and norepinephrine and serotonin induced changes. Comparison with dL-amphetamine.
Fanelli O; Mazzoncini V; Trallori L
Arzneimittelforschung; 1974 Dec; 24(12):2025-9. PubMed ID: 4480283
[No Abstract] [Full Text] [Related]
5. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
[No Abstract] [Full Text] [Related]
6. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine, fenfluramine and their N-dealkylated metabolites: effect on monoamine concentrations in rat tissues.
Morgan CD; Cattabeni F; Costa E
J Pharmacol Exp Ther; 1972 Jan; 180(1):127-35. PubMed ID: 5010410
[No Abstract] [Full Text] [Related]
8. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
Proctor CD; Kirby J; Wood MH; Wade LH; King PK
Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
[No Abstract] [Full Text] [Related]
9. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
Andén NE
Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
[No Abstract] [Full Text] [Related]
10. A comparison of the effects of fenfluramine and amphetamine on uptake release and catabolism of norepinephrine in rat brain.
Ziance RJ; Rutledge CO
J Pharmacol Exp Ther; 1972 Jan; 180(1):118-26. PubMed ID: 5010409
[No Abstract] [Full Text] [Related]
11. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
Koe BK; Weissman A; Welch WM; Browne RG
J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacology and biochemistry of fenfluramine].
Duhault J
Vie Med Can Fr; 1973; 2(2):141-7. PubMed ID: 4574870
[No Abstract] [Full Text] [Related]
13. Activity of ibopamine on central nervous system in mice and rats.
Ferrini R; Miragoli G; Sala R; Reggiani A
Arzneimittelforschung; 1986 Feb; 36(2A):327-30. PubMed ID: 3707643
[TBL] [Abstract][Full Text] [Related]
14. On the central antiserotonin action of trazodone.
Baran L; Maj J; Rogóz Z; Skuza G
Pol J Pharmacol Pharm; 1979; 31(1):25-33. PubMed ID: 482164
[TBL] [Abstract][Full Text] [Related]
15. Effects of d-amphetamine sulfate given to pregnant mice on activity and on catecholamines in the brains of offspring.
Middaugh LD; Blackwell LA; Santos CA; Zemp JW
Dev Psychobiol; 1974 Sep; 7(5):429-38. PubMed ID: 4426470
[No Abstract] [Full Text] [Related]
16. Evidence against a role of brain 5-hydroxytryptamine in the development of physical dependence upon morphine in mice.
Marshall I; Grahame-Smith DG
J Pharmacol Exp Ther; 1971 Dec; 179(3):634-41. PubMed ID: 4257807
[No Abstract] [Full Text] [Related]
17. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS.
Fuxe K; Hökfelt T
Triangle; 1971; 10(3):73-84. PubMed ID: 5138525
[No Abstract] [Full Text] [Related]
18. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
Grahame-Smith DG
J Neurochem; 1971 Jun; 18(6):1053-66. PubMed ID: 4254940
[No Abstract] [Full Text] [Related]
19. [Comparative study of the central effects of M-14012-A and SKF-525-A in rodents].
Garrido J; Pérez Naranjo J; Martínez Roldán C
Arch Farmacol Toxicol; 1983 Aug; 9(2):191-202. PubMed ID: 6660935
[No Abstract] [Full Text] [Related]
20. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
Cooper BR; Breese GR; Grant LD; Howard JL
J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
